Luisa Savoldi

1.1k total citations
23 papers, 167 citations indexed

About

Luisa Savoldi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Luisa Savoldi has authored 23 papers receiving a total of 167 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Luisa Savoldi's work include Breast Cancer Treatment Studies (7 papers), Breast Lesions and Carcinomas (4 papers) and Cancer Treatment and Pharmacology (3 papers). Luisa Savoldi is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Breast Lesions and Carcinomas (4 papers) and Cancer Treatment and Pharmacology (3 papers). Luisa Savoldi collaborates with scholars based in Italy, Brazil and France. Luisa Savoldi's co-authors include Giorgio Cocconi, C. Boni, Annamaria Guazzi, Nadia Naldi, Rita Nizzoli, Cecilia Bozzetti, Giancarlo Bisagni, Roberta Camisa, Ermanno Rondini and R. Camisa and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Luisa Savoldi

22 papers receiving 163 citations

Peers

Countries citing papers authored by Luisa Savoldi

Since Specialization

Citations

This map shows the geographic impact of Luisa Savoldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Savoldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Savoldi more than expected).

Fields of papers citing papers by Luisa Savoldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Savoldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Savoldi. The network helps show where Luisa Savoldi may publish in the future.

Co-authorship network of co-authors of Luisa Savoldi

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Savoldi. A scholar is included among the top collaborators of Luisa Savoldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Savoldi. Luisa Savoldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS Study 2023 ·Cancers ·Salvatore Cozzi, Alessio Bruni, (unknown), Paolo Borghetti, Vieri Scotti, Davide Franceschini, Michele Fiore, (unknown), Fabrizio Salvi, Marco Galaverni, Luisa Savoldi, Luca Braglia, A. Botti, (unknown), (unknown), Frank Lohr, Cinzia Iotti, Patrizia Ciammella	4
2	Efficacy and safety of a colostrum- and Aloe vera-based oral care protocol to prevent and treat severe oral mucositis in patients undergoing hematopoietic stem cell transplantation: a single-arm phase II study 2022 ·Annals of Hematology ·Monica Guberti, Stefano Botti, (unknown), (unknown), Luisa Savoldi, Andrea Fusco, Francesco Merli, Michela Piredda, Maria Grazia De Marinis	3
3	Stem cell transplantation patients receiving a novel oral care protocol for oral mucositis prevention and treatment: patient-reported outcomes and quality of life 2022 ·Supportive Care in Cancer ·Monica Guberti, Stefano Botti, Andrea Fusco, (unknown), (unknown), Luisa Savoldi, Nicola Serra, Francesco Merli, Michela Piredda, Maria Grazia De Marinis	3
4	Safety of Inhomogeneous Dose Distribution IMRT for High-Grade Glioma Reirradiation: A Prospective Phase I/II Trial (GLIORAD TRIAL) 2022 ·Cancers ·Patrizia Ciammella, Salvatore Cozzi, A. Botti, Lucia Giaccherini, Roberto Sghedoni, (unknown), Manuela Napoli, Rosario Pascarella, Anna Pisanello, Marco Russo, Francesco Cavallieri, (unknown), Silvio Cavuto, Luisa Savoldi, Cinzia Iotti, Mauro Iori	5
5	Postoperative hypoparathyroidism after completion thyroidectomy for well-differentiated thyroid cancer 2021 ·European Journal of Endocrinology ·Davide Giordano, Cecilia Botti, Simonetta Piana, Michele Zini, Andrea Frasoldati, (unknown), Silvio Cavuto, Luisa Savoldi, (unknown), Angelo Ghidini	14
6	Impact of 2013 ASCO/CAP guidelines on HER2 determination of invasive breast cancer: A single institution experience using frontline dual-color FISH 2017 ·The Breast ·Moira Ragazzi, Alessandra Bisagni, Elisa Gasparini, Elisabetta Kuhn, (unknown), Ione Tamagnini, (unknown), (unknown), Giuseppe Falco, Guglielmo Ferrari, Luca Braglia, Luisa Savoldi, Alessandra Bologna, Roberto Di Cicilia, Giancarlo Bisagni, Giorgio Gardini	11
7	Impact of 2013 ASCO/CAP guidelines on HER2 determination of invasive breast cancer: A single institution experience using frontline dual-color FISH. 2017 ·Journal of Clinical Oncology ·Elisa Gasparini, Moira Ragazzi, Alessandra Bisagni, Elisabetta Kuhn, (unknown), Ione Tamagnini, Moira Foroni, Giuseppe Falco, Guglielmo Ferrari, Luca Braglia, Luisa Savoldi, Alessandra Bologna, Roberto Di Cicilia, Giorgio Gardini, Giancarlo Bisagni	0
8	Is early integration of palliative care feasible and acceptable for advanced respiratory and gastrointestinal cancer patients? A phase 2 mixed-methods study 2017 ·Palliative Medicine ·Massimo Costantini, Giovanni Apolone, Silvia Tanzi, (unknown), Ermanno Rondini, Monica Guberti, Silvia Fanello, Silvio Cavuto, Luisa Savoldi, Roberto Piro, Daniela Mecugni, Silvia Di Leo	9
9	Pei regimen: a therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive cases 2015 ·Journal of Translational Medicine ·C. Boni, Maria Pagano, (unknown), (unknown), Luca Braglia, Luisa Savoldi, Francesca Zanelli	2
10	Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase splice site variant: the need for further revision of dose and schedule 2013 ·Internal and Emergency Medicine ·Elena Magnani, Enrico Farnetti, Davide Nicoli, Bruno Casali, Luisa Savoldi, Chiara Focaccetti, C. Boni, Adriana Albini, Maria Banzi	14
11	A Longitudinal Study of Thyroidectomized Patients in a Region of Northern Italy: Benign Versus Malignant Disease 2013 ·Endocrine Practice ·Roberto Negro, Hossein Gharib, Luisa Savoldi, Verter Barbieri, Roberto Valcavi	1
12	Complicações Orais em Pacientes em Tratamento Quimioterápico na Unacon, no Município de Itajaí/SC 2011 ·Americanae (AECID Library) ·Maria Regina Orofino Kreuger, Luisa Savoldi, (unknown), (unknown)	5
13	[The predictive value of a risk assessment tool for falls in elderly hospitalized patients]. 2009 ·PubMed ·(unknown), Anne Destrebecq, Luisa Savoldi	2
14	Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomes 2005 ·Annals of Oncology ·Giorgio Cocconi, (unknown), C. Boni, Giancarlo Bisagni, Ermanno Rondini, Maria Angela Bella, (unknown), Luisa Savoldi, (unknown), R. Camisa, Paolo Bruzzi	7
15	Randomized trial comparing cyclophosphamide, methotrexate, and 5–fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma 2002 ·Cancer ·Giorgio Cocconi, (unknown), C. Boni, Giancarlo Bisagni, Guido Ceci, Ermanno Rondini, Mariangela Bella, (unknown), Luisa Savoldi, Roberta Camisa, Paolo Bruzzi	6
16	Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: A phase II study of the Italian oncology group for clinical research (goirc) 2000 ·International Journal of Cancer ·C. Boni, Giancarlo Bisagni, Luisa Savoldi, Gabriella Moretti, Ermanno Rondini, M. Sassi, (unknown), Tommaso De Pas, Vittorio Franciosi, Antonio Pazzola, Rafael Vignoli, Maria Banzi, (unknown)	6
17	Three new active cisplatin‐containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial 1999 ·Breast Cancer Research and Treatment ·Giorgio Cocconi, Giancarlo Bisagni, Guido Ceci, (unknown), Vincenzo De Lisi, Rodolfo Passalacqua, (unknown), C. Boni, Paolo Morandi, Luisa Savoldi	11
18	Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC) 1998 ·European Journal of Cancer ·C. Boni, Luisa Savoldi, Giancarlo Bisagni, Guido Ceci, Lucio Crinò, Vincenzo De Lisi, Francesco Di Costanzo, Laura Lasagni, (unknown), Gabriella Moretti, Ermanno Rondini, M. Sassi, (unknown)	2
19	Ifosfamide Bolus Followed by Five Days Continuous Infusion in Extensively Pretreated Patients with Advanced Breast Cancer: A Phase II Study 1998 ·Tumori Journal ·Giancarlo Bisagni, C. Boni, (unknown), Gabriella Moretti, Ermanno Rondini, M. Sassi, (unknown), Luisa Savoldi	3
20	Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma 1994 ·Breast Cancer Research and Treatment ·Cecilia Bozzetti, Rita Nizzoli, Nadia Naldi, (unknown), Luisa Savoldi, Roberta Camisa, Annamaria Guazzi, Giorgio Cocconi	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact